Anna-Maija Vanhatalo

Effect of Chaga Mushroom as a Natural Immune Modulator on Upper-Respiratory Tract Infections (URTIs) and Psychological Mood State Eevia Health study conducted in collaboration with Dr. Shawn M. Talbott and GLH Nutrition, November 17, 2021 Background Heavy exercise or intense training may increase susceptibility to upper respiratory tract infections (URTI) (Nieman et al., 1990; Peters […]

Please read the full abstract of the study here. Eevia Health Plc (” Eevia” or” The Company”) has concluded a human clinical study of the effects of Eevia’s branded ingredient Feno-Chaga® Organic on Upper-Respiratory Tract Infections (URTIs) and Psychological Mood State with positive and promising results. Forty (40) healthy long-distance (marathon) runners participated in a […]

Eevia Health Plc, (”Eevia” or ”The Company”), announces that it has received sales orders from a leading organic supplement brand for supply of the Fenoprolic® 70 Organic (organic pine bark extract). The sales value of this start order is c.65,000 EUR, but the customer has a strong record on new product launches, and it is therefore expected to create repeat sales of this product going forward.    Eevia exhibited at the trade show “Supply Side West” in Las Vegas this week (25-28.10.21). In […]

Eevia Health Plc, (”Eevia” or ”The Company”), has installed new capacities and automation equipment for processing and evaporation of natural plant extract liquids. As of August 1st, the newly installed machines and technologies are working satisfactorily, with improved yield, productivity, and cost efficiency. One investment is related to improved berry processing, included a new loading […]

Eevia Health Plc, (”Eevia” or ”The Company”), announces that it has received sales orders from Ingredient Plus of Australia for supply of bilberry extract with minimum 36% anthocyanins. The sales value of these orders is c. SEK 3 million, which to be prepaid and delivered in Q3-21. Eevia considers these orders to be repeat business […]

Eevia Health Plc recently succeeded with an IPO equity round, issuing new 3 451 000 shares with gross proceeds of approx. SEK 26,2 million, leading to a total of 13 951 500 shares in the company as per today’s date. Trading in shares will take place from today, June 29, 2021 at Spotlight Stock Market. The short name […]

Eevia Health Plc, (”Eevia” or ”The Company”), a leading health ingredient manufacturer from Finland, today announces that it has entered a multi-year sales agreement for the US market with a key international customer. The agreement is for the supply of a standardized berry extract. The first three years of the sales agreement provides for a […]

The subscription of shares started today. Information memorandum and teasers (both in English and in Swedish) are now available and you can find them below. Check more information on our IPO pages! Information memorandum Eevia Health Oyj June 2021Teaser Eevia Health Oyj June (English)Teaser Eevia Health Oyj June (Swedish)

Press Release 01.06.2021 Finnish functional food company Eevia Health – a leading supplier of bioactive plant extracts from berries, mushrooms and pine trees – to list on Spotlight Stock Market NOT FOR PUBLICATION OR DISTRIBUTION, WHETHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES AUSTRALIA, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, SWITZERLAND, […]

Seinäjoki, Finland, May 18th, 2021 – Eevia releases an adjusted Interim Report for Q1-21 and makes plans to list its shares in Sweden. After a shareholders’ decision on April 21st, Eevia Health Oy has changed its legal form from a private limited company to a public limited company and became Eevia Health Oyj. In the […]